# Study of FF-10502-01 in Patients With Advanced Solid Tumors and Lymphomas

> **NCT02661542** · PHASE1,PHASE2 · COMPLETED · sponsor: **Fujifilm Pharmaceuticals U.S.A., Inc.** · enrollment: 106 (actual)

## Conditions studied

- Solid Tumors
- Lymphomas

## Interventions

- **DRUG:** FF-10502-01

## Key facts

- **NCT ID:** NCT02661542
- **Lead sponsor:** Fujifilm Pharmaceuticals U.S.A., Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2020-11-05
- **Final completion:** 2020-11-05
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02661542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02661542, "Study of FF-10502-01 in Patients With Advanced Solid Tumors and Lymphomas". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT02661542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*